Evaxion Biotech As Stock Probability of Future Stock Price Finishing Over 1.14
| EVAX Stock | USD 1.14 0.05 4.20% |
Evaxion |
Evaxion Biotech Target Price Odds to finish over 1.14
The tendency of Evaxion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.14 | 90 days | 1.14 | roughly 96.0 |
Based on a normal probability distribution, the odds of Evaxion Biotech to move above the current price in 90 days from now is roughly 96.0 (This Evaxion Biotech AS probability density function shows the probability of Evaxion Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.2 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Evaxion Biotech will likely underperform. Additionally Evaxion Biotech AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Evaxion Biotech Price Density |
| Price |
Predictive Modules for Evaxion Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evaxion Biotech AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Evaxion Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Evaxion Biotech is not an exception. The market had few large corrections towards the Evaxion Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Evaxion Biotech AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Evaxion Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.44 | |
β | Beta against Dow Jones | 1.20 | |
σ | Overall volatility | 0.67 | |
Ir | Information ratio | -0.26 |
Evaxion Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Evaxion Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Evaxion Biotech AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Evaxion Biotech AS generated a negative expected return over the last 90 days | |
| Evaxion Biotech AS has high historical volatility and very poor performance | |
| Evaxion Biotech AS may become a speculative penny stock | |
| Evaxion Biotech AS has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 73 K. Net Loss for the year was (22.12 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Evaxion Biotech AS currently holds about 25.25 M in cash with (17.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.06. | |
| Evaxion Biotech AS has a frail financial position based on the latest SEC disclosures | |
| Roughly 25.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Evaxion Biotech AS Shares Sold by Invst LLC |
Evaxion Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Evaxion Stock often depends not only on the future outlook of the current and potential Evaxion Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evaxion Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.7 M | |
| Cash And Short Term Investments | 5.6 M |
Evaxion Biotech Technical Analysis
Evaxion Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Evaxion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Evaxion Biotech AS. In general, you should focus on analyzing Evaxion Stock price patterns and their correlations with different microeconomic environments and drivers.
Evaxion Biotech Predictive Forecast Models
Evaxion Biotech's time-series forecasting models is one of many Evaxion Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Evaxion Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Evaxion Biotech AS
Checking the ongoing alerts about Evaxion Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Evaxion Biotech AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Evaxion Biotech AS generated a negative expected return over the last 90 days | |
| Evaxion Biotech AS has high historical volatility and very poor performance | |
| Evaxion Biotech AS may become a speculative penny stock | |
| Evaxion Biotech AS has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 73 K. Net Loss for the year was (22.12 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Evaxion Biotech AS currently holds about 25.25 M in cash with (17.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.06. | |
| Evaxion Biotech AS has a frail financial position based on the latest SEC disclosures | |
| Roughly 25.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Evaxion Biotech AS Shares Sold by Invst LLC |
Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.